{"companyId":285098,"requestedLanguage":"en","resolvedLanguage":"en","availableLanguages":["en","ja"],"companyName":"Telix Pharmaceuticals Limited","headOfficeLocation":"55 Flemington Road, Level 4 North Melbourne, VIC 3051 Australia","presidentName":"Christian Behrenbruch","companySummary":null,"stockCode":"TLX","currency":"USD","capital":null,"sales":null,"employees":1184,"employeesConsolidated":null,"humanCheck":false,"domains":["telixpharma.com"],"businessContents":["Radiopharmaceutical development","Cancer diagnostic imaging and therapy products"],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://telixpharma.com/","scoreAbout":300,"scoreBusiness":200,"scoreGroup":0,"scoreCustomer":0}]}